COMP <GO>
CNA vs JPM // PIOTROSKI F-SCORE QUALITY
CNA Financial Corporation (NYSE) VS. JPMorgan Chase & Co. (NYSE) • 15-METRIC TALLY: CNA 10
— JPM 4
▲ PIOTROSKI F-SCORE QUALITY LEADER: CNA
LAST: $48.68 (-0.39%) • MKT CAP: $13.22B
piotroski-score
8/9
LAST: $337.04 (-1.90%) • MKT CAP: $895.92B
piotroski-score
2/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CNA VS. JPM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CNA | JPM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 19.70% | 17.37% | +2.33 | CNA | /roic <GO> |
| EV/EBITDA & P/E Valuation | 4.8x | 9.7x | -4.87 | CNA | /valuation <GO> |
| Free Cash Flow Yield | 18.18% | -18.14% | +36.32 | CNA | /fcf-yield <GO> |
| Operating Margin | 75.00% | 42.07% | +32.93 | CNA | /operating-margins <GO> |
| Net Profit Margin | 68.00% | 32.63% | +35.37 | CNA | /net-margins <GO> |
| Revenue Growth (YoY) | -2.00% | 13.53% | -15.53 | JPM | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 7.92% | 1.96% | +5.96 | CNA | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.57 | 0.37 | +0.20 | CNA | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 8/9 | 2/9 | +6.00 | CNA | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.60% | 4.84% | +1.76 | JPM | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 57.3 | 49.0 | +8.26 | CNA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.92 | 1.00 | -0.08 | JPM | /macro-sensitivity <GO> |
| Forward P/E Multiple | 9.6x | 13.6x | -3.97 | CNA | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $13.22B | $895.92B | -$882.69B | JPM | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CNA REV | JPM REV | CNA GROSS % | JPM GROSS % | CNA FCF | JPM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.58B | $182.45B | 44.0% | — | $2.40B | -$147.78B |
| FY 2024 | $1.61B | $177.56B | 44.0% | — | $2.48B | -$42.01B |
| FY 2023 | $1.62B | $158.10B | 44.0% | — | $2.21B | $12.97B |
| FY 2022 | — | $128.69B | — | — | — | $107.12B |
| FY 2021 | — | $121.65B | — | — | — | $78.08B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CNA // BETA 0.92
JPM // BETA 1.00